Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Kestra Medical Technologies (KMTS) Invested Capital (2024 - 2026)

Kestra Medical Technologies (KMTS) has disclosed Invested Capital for 3 consecutive years, with $288.0 million as the latest value for Q1 2026.

  • Quarterly Invested Capital rose 234.48% to $288.0 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $288.0 million through Jan 2026, up 234.48% year-over-year, with the annual reading at $246.5 million for FY2025, 247.75% up from the prior year.
  • Invested Capital for Q1 2026 was $288.0 million at Kestra Medical Technologies, up from $164.1 million in the prior quarter.
  • The five-year high for Invested Capital was $288.0 million in Q1 2026, with the low at -$236.5 million in Q4 2024.
  • Average Invested Capital over 3 years is -$10.8 million, with a median of -$166.8 million recorded in 2024.
  • Peak annual rise in Invested Capital hit 247.75% in 2025, while the deepest fall reached 14.38% in 2025.
  • Over 3 years, Invested Capital stood at -$236.5 million in 2024, then soared by 169.37% to $164.1 million in 2025, then soared by 75.52% to $288.0 million in 2026.
  • According to Business Quant data, Invested Capital over the past three periods came in at $288.0 million, $164.1 million, and $225.6 million for Q1 2026, Q4 2025, and Q3 2025 respectively.